IP Library Assignment 029839/0959
Patent Assignment
Reel/Frame 029839/0959

Assignment of Assignor's Interest

Recorded: 2013-02-20 Pages: 3
Assignor
BAYER PHARMA AG
Executed: 2013-01-31
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
ALFRED-NOBEL-STRASSE 10, MONHEIM, 40789, GERMANY
Covered Properties (24)
Regulation of Human Transmembrane Serine Protease
Patent: 6,734,006 →
Application: 09/879,792 →
Publication: US 2002/0061850
Corin, a Serine Protease
Patent: 6,806,075 →
Application: 09/959,392 →
Regulation of Human Prostasin-Like Serine Protease
Patent: 7,049,420 →
Application: 10/311,591 →
Publication: US 2004/0141962
Sustained-Release Preparations of Quinolone Antibiotics and Method for Preparation Thereof
Patent: 7,709,022 →
Application: 10/311,913 →
Publication: US 2004/0024018
Regulation of Human Adenylate Cyclase
Patent: 7,205,135 →
Application: 10/416,577 →
Publication: US 2004/0063174
Regulation of Human Aminopeptidase N
Patent: 7,129,077 →
Application: 10/483,192 →
Publication: US 2004/0241156
Novel Tissue Factor Targeted Antibodies as Anticoagulants
Patent: 7,579,000 →
Application: 10/512,215 →
Publication: US 2006/0166284
Acylglycerol Acyltransferase-Like Protein Mgat-X1 and Uses Thereof
Patent: 7,803,593 →
Application: 10/573,500 →
Publication: US 2008/0311102
Regulation of Human Ceramide Kinase
Patent: 7,037,700 →
Application: 10/631,958 →
Publication: US 2004/0192580
Regulation of Human Transmembrane Serine Protease
Patent: 7,314,730 →
Application: 10/806,370 →
Publication: US 2004/0209327
Regulation of Human Caspase-1-Like Protease
Patent: 7,192,732 →
Application: 11/357,125 →
Publication: US 2006/0141552
Regulation of Human Prostasin-Like Serine Protease
Patent: 7,538,205 →
Application: 11/359,554 →
Publication: US 2006/0154293
Method of Preparing Sustained-Release Preparations of Quinolone Antibiotics
Patent: 7,780,986 →
Application: 11/560,594 →
Publication: US 2007/0065509
Sustained-Release Preparations of Quinolone Antibiotics
Patent: 8,187,632 →
Application: 11/762,831 →
Publication: US 2007/0237824
Polynucleotides Encoding Anticoagulant Fusion Proteins
Patent: 7,622,457 →
Application: 11/766,155 →
Publication: US 2008/0019985
Methods of Using Novel Tissue Factor Targeted Thrombomodulin Fusion Proteins as Anticoagulants
Patent: 7,622,122 →
Application: 11/766,160 →
Publication: US 2008/0020965
Regulation of Human Transmembrane Serine Protease
Patent: 7,622,292 →
Application: 11/936,155 →
Publication: US 2009/0182121
LTBP2 as a Biomarker and Diagnostic Target
Patent: 8,088,584 →
Application: 12/444,596 →
Publication: US 2010/0028264
PRSS23 as a Biomarker and Diagnostic Target
Application: 12/445,494 →
Publication: US 2010/0104501
Polynucleotides Encoding Anticoagulant Antibodies
Patent: 7,960,532 →
Application: 12/503,893 →
Publication: US 2009/0317390
Monospecific and Multispecific Antibodies and Method of Use
Patent: 9,624,309 →
Application: 12/671,942 →
Publication: US 2011/0229476
Antibodies to TNF Alpha
Patent: 8,399,627 →
Application: 12/808,608 →
Publication: US 2010/0297700
Acylglycerol Acyltransferase-Like Protein Mgat-X1 and Uses Thereof
Patent: 8,343,745 →
Application: 12/854,524 →
Publication: US 2011/0086013
Targeted soluble tissue factor antibody-thrombomodulin fusion protein as an anticoagulant
Application: 60/376,566 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Change of Name Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
Change of Name Nov 14, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029297/0001 →